Does FILGRASTIM Cause Diffuse large b-cell lymphoma recurrent? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with FILGRASTIM (NYPOZI txid). This represents 0.1% of all adverse event reports for FILGRASTIM.
20
Reports of Diffuse large b-cell lymphoma recurrent with FILGRASTIM
0.1%
of all FILGRASTIM reports
9
Deaths
10
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From FILGRASTIM?
Of the 20 reports, 9 (45.0%) resulted in death, 10 (50.0%) required hospitalization, and 3 (15.0%) were considered life-threatening.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FILGRASTIM. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does FILGRASTIM Cause?
Off label use (1,930)
Febrile neutropenia (1,570)
Neutropenia (1,431)
Death (1,213)
Pyrexia (1,085)
Diarrhoea (739)
Nausea (718)
Bone pain (706)
Thrombocytopenia (697)
Anaemia (626)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which FILGRASTIM Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
FILGRASTIM vs FILGRASTIM-AAFI
FILGRASTIM vs FILGRASTIM-SNDZ
FILGRASTIM vs FINASTERIDE
FILGRASTIM vs FINASTERIDE\TAMSULOSIN
FILGRASTIM vs FINERENONE